Curis (CRIS) Non Operating Investment Income (2010 - 2013)

Curis (CRIS) reported Non Operating Investment Income of -$1.1 million for Q3 2013, down 169.57% on a YoY basis from $1.5 million in Q3 2012, and down 421.99% quarter-over-quarter from $333141.0 in Q2 2013.

Curis (CRIS) Non Operating Investment Income (2010 - 2013) Analysis & Trends

Curis has reported Non Operating Investment Income for 4 years, with the latest figure at -$1.1 million in Q3 2013.

  • For the quarter ending Q3 2013, Non Operating Investment Income fell 169.57% year-over-year to -$1.1 million; the trailing twelve-month figure through Sep 2013 stood at $306892.0 (up 165.66% YoY), and the FY2011 full-year result was -$2.8 million, down 578.7% from the prior year.
  • Non Operating Investment Income for Q3 2013 stood at -$1.1 million, down from $333141.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $1.5 million in Q3 2012, with the low at -$1.5 million in Q4 2011.
  • Historically, Non Operating Investment Income has averaged -$137620.7 across 4 years, with a median of $23865.5 in 2010.
  • The largest YoY upside for Non Operating Investment Income was 182.98% in 2011 against a maximum downside of 905.33% in 2011.
  • Curis' Non Operating Investment Income stood at $542855.0 in 2010, then plunged by 380.33% to -$1.5 million in 2011, then jumped by 201.32% to $1.5 million in 2012, then slumped by 169.57% to -$1.1 million in 2013.
  • The last three Non Operating Investment Income figures came in at -$1.1 million (Q3 2013), $333141.0 (Q2 2013), and $1.5 million (Q3 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 235,807.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 230,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Curis 8.27 Mn -6.73 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2013 -1.07 Mn
Sep 30, 2013 -1.07 Mn
Jun 30, 2013 333,141.00
Jun 30, 2013 333,141.00
Sep 30, 2012 1.54 Mn
Sep 30, 2012 1.54 Mn
Jun 30, 2012 -495,341.00
Jun 30, 2012 -495,341.00
Mar 31, 2012 7,941.00
Mar 31, 2012 7,941.00
Dec 31, 2011 -1.52 Mn
Dec 31, 2011 -1.52 Mn
Sep 30, 2011 587,184.00
Sep 30, 2011 587,184.00
Jun 30, 2011 -320,440.00
Jun 30, 2011 -320,440.00
Mar 31, 2011 -1.50 Mn
Mar 31, 2011 -1.50 Mn
Dec 31, 2010 542,855.00
Dec 31, 2010 542,855.00